tiprankstipranks
Trending News
More News >
Champions Oncology (CSBR)
:CSBR
US Market

Champions Oncology (CSBR) Income Statement

Compare
140 Followers

Champions Oncology Income Statement

Last quarter (Q1 2026), Champions Oncology's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Champions Oncology's net income was $-466.00K. See Champions Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 56.94M$ 50.16M$ 53.87M$ 49.11M$ 41.04M
Gross Profit
$ 28.55M$ 20.75M$ 24.34M$ 25.48M$ 19.57M
Operating Expenses
$ 24.00M$ 28.11M$ 28.79M$ 24.87M$ 19.23M
Depreciation and Amortization
$ 1.64M$ 1.87M$ 3.20M$ 2.41M$ 1.58M
EBITDA
$ 6.49M$ -5.05M$ -2.07M$ 2.23M$ 366.00K
Operating Income
$ 4.55M$ -7.36M$ -4.45M$ 607.00K$ 338.00K
Other Income/Expenses
$ 73.00K$ 48.00K$ -11.00K$ -24.00K$ 99.00K
Pretax Income
$ 4.63M$ -7.31M$ -5.27M$ 583.00K$ 437.00K
Net Income
$ 4.70M$ -7.28M$ -5.33M$ 548.00K$ 362.00K
Per Share Metrics
Basic EPS
$ 0.34$ -0.54$ -0.39$ 0.04$ 0.03
Diluted EPS
$ 0.33$ -0.54$ -0.39$ 0.04$ 0.02
Weighted Average Shares Outstanding
13.66M 13.55M 13.54M 13.20M 13.14M
Weighted Average Shares Outstanding (Diluted)
14.27M 13.55M 13.54M 14.16M 14.57M
Currency in USD

Champions Oncology Earnings and Revenue History